Literature DB >> 7521928

Interaction between tacrolimus and erythromycin.

C Jensen, M Jordan, R Shapiro, V Scantlebury, T Hakala, J Fung, T Starzl, R Venkataramanan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7521928     DOI： 10.1016/s0140-6736(94)92383-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Tacrolimus/cerivastatin interaction study in liver transplant recipients.

Authors:  W Mück; D A Neal; O Boix; B Voith; R Hasan; G J Alexander
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

Review 2.  Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU.

Authors:  Isabel Spriet; Wouter Meersseman; Jan de Hoon; Sandrina von Winckelmann; Alexander Wilmer; Ludo Willems
Journal:  Intensive Care Med       Date:  2009-01-09       Impact factor: 17.440

3.  Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.

Authors:  S R Katari; M Magnone; R Shapiro; M Jordan; V Scantlebury; C Vivas; A Gritsch; J McCauley; T Starzl; A J Demetris; P S Randhawa
Journal:  Clin Transplant       Date:  1997-06       Impact factor: 2.863

Review 4.  Clinically significant drug interactions with new immunosuppressive agents.

Authors:  C Mignat
Journal:  Drug Saf       Date:  1997-04       Impact factor: 5.606

5.  Tacrolimus and cerivastatin pharmacokinetics and adverse effects after single and multiple dosing with cerivastatin in renal transplant recipients.

Authors:  Lutz Renders; Christian S Haas; Jan Liebelt; Martin Oberbarnscheidt; Harald O Schöcklmann; Ulrich Kunzendorf
Journal:  Br J Clin Pharmacol       Date:  2003-08       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

Review 7.  Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors:  Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 8.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

9.  Outcomes Following Macrolide Use in Kidney Transplant Recipients.

Authors:  Rachel Jeong; Robert R Quinn; Krista L Lentine; Anita Lloyd; Pietro Ravani; Brenda Hemmelgarn; Branko Braam; Amit X Garg; Kevin Wen; Anita Wong-Chan; Sita Gourishankar; Ngan N Lam
Journal:  Can J Kidney Health Dis       Date:  2019-02-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.